Takeda M, Kato A, Kobune F, Sakata H, Li Y, Shioda T, Sakai Y, Asakawa M, Nagai Y
Department of Viral Infection, Institute of Medical Science, University of Tokyo, Shirokanedai 4-6-1, Minato-ku, Tokyo 108-8639, USA.
J Virol. 1998 Nov;72(11):8690-6. doi: 10.1128/JVI.72.11.8690-8696.1998.
Measles virus (MV) isolated in B95a cells, a marmoset B-cell line, retains full pathogenicity for cynomolgus monkeys, while its derivative obtained by adaptation to the growth in Vero cells, a monkey kidney cell line, loses the pathogenic potential (F. Kobune, H. Sakata, and A. Sugiura, J. Virol. 64:700-705, 1990). Here, we show with a pair of strains, a fresh isolate (9301B) in B95a cells and its Vero cell-adapted form (9301V), that the in vivo attenuation parallels the decrease of replication and syncytium-inducing capabilities in the original B95a cells and that these in vitro phenotypes are attributable to impediment of transcription, which is already obvious at the level of primary transcription catalyzed by the virion-associated RNA polymerase. On the other hand, cell fusion assays detected no functional difference between the glycoproteins of the two viruses. Essentially the same transcriptional impediment with reduced syncytium induction following Vero cell adaptation was found with two other pairs of strains that had been similarly prepared. Nucleotide sequence comparison between the 9301B and 9301V viruses revealed that a few (at most five) amino acid changes, which sporadically took place in the polymerase (L and P proteins) and/or accessory V and C proteins, were responsible for the in vitro and in vivo attenuation through adaptation to growth in Vero cells.
在狨猴B细胞系B95a细胞中分离得到的麻疹病毒(MV),对食蟹猴仍具有完全致病性,而其通过适应猴肾细胞系Vero细胞生长而获得的衍生物则失去了致病潜力(F. Kobune、H. Sakata和A. Sugiura,《病毒学杂志》64:700 - 705,1990年)。在此,我们使用一对毒株,即B95a细胞中的新鲜分离株(9301B)及其Vero细胞适应株(9301V),证明体内减毒与在原始B95a细胞中复制和诱导合胞体能力的降低平行,并且这些体外表型归因于转录障碍,这在由病毒体相关RNA聚合酶催化的初级转录水平上已经很明显。另一方面,细胞融合试验未检测到两种病毒糖蛋白之间的功能差异。在另外两对类似制备的毒株中也发现了Vero细胞适应后转录障碍基本相同且合胞体诱导减少的情况。9301B和9301V病毒之间的核苷酸序列比较显示,在聚合酶(L和P蛋白)和/或辅助V和C蛋白中偶尔发生的少数(最多五个)氨基酸变化,是通过适应Vero细胞生长导致体外和体内减毒的原因。